Navigation Links
FDA Approves Xarelto to Prevent Stroke in People With Common Type of Abnormal Heart Rhythm
Date:11/4/2011

SILVER SPRING, Md., Nov. 4, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved the anti-clotting drug Xarelto (rivaroxaban) to reduce the risk of stroke in people who have abnormal heart rhythm (non-valvular atrial fibrillation).

(Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO)

Atrial fibrillation occurs in more than 2 million Americans and is one of the most common types of abnormal heart rhythm. In atrial fibrillation, the beating of the heart's two upper heart chambers (atria) is irregular and poorly coordinated. This leads to blood pooling in these chambers, resulting in blood clots. Non-valvular atrial fibrillation refers to atrial fibrillation in patients who do not have significant problems in their heart valves.

"Atrial fibrillation can lead to the formation of blood clots, which can travel to the brain, blocking blood flow and causing a disabling stroke," said Norman Stockbridge, M.D., Ph.D., director of the Division of Cardiovascular and Renal Products in the FDA's Center for Drug Evaluation and Research. "This approval gives doctors and patients another treatment option for a condition that must be managed carefully."

A stroke occurs if the flow of blood to a portion of the brain is blocked. If brain cells die or are damaged because of a stroke, symptoms occur in the parts of the body that these brain cells control. Stroke symptoms include sudden weakness; paralysis or numbness of the face, arms, or legs; trouble speaking or understanding speech; and trouble seeing.

The safety and efficacy of Xarelto were evaluated in a clinical trial with more than 14,000 patients comparing Xarelto with the anti-clotting drug warfarin. In the trial, Xarelto was similar to warfarin in its ability to prevent stroke.

For people taking the drug for atrial fibrillation, Xarelto should be
'/>"/>

SOURCE U.S. Food and Drug Administration
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
3. FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
4. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
5. FDA Approves MiddleBrooks Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
6. FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria
7. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
8. U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)
9. U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older
10. FDA Approves HIFU Clinical Trial for Recurrent Prostate Cancer
11. EPA Approves XDS-CALUX(R) as Alternate Dioxin Test Method 4435
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... N.C. , April 17, 2015  Healthcare ... creation of many new forms of provider networks, ... Care Organizations (ACOs). The rapid evolution of these ... adapt their access, pricing and service delivery systems ... To help the pharma sector adapt ...
(Date:4/17/2015)... Inivata, a Cambridge, England ... presence at the 2015 American Association for Cancer Research (AACR) ... Nitzan Rosenfeld and a poster presentation. Michael Stocum ... - 22 nd . The presentation, entitled ... forms part of a session on Recent Advances ...
(Date:4/17/2015)... 17, 2015 Research and Markets ( ... "ADME-Toxicology Testing - Global Strategic Business Report" report ... worldwide markets for ADME-Toxicology Testing in US$ Million by ... ADME Testing. The report provides separate comprehensive ... Japan , Europe ...
Breaking Medicine Technology:Pharmaceutical Industry Struggling to Better Serve Provider Networks Such as Accountable Care Organizations (ACOs) 2Inivata Co-founder Nitzan Rosenfeld to Present at AACR Annual Meeting 2ADME-Toxicology Testing (In-Vivo, & In-Vitro) Market - Global Strategic Business Report 2015: Pharma Industry Renews Focus on Cost Optimization 2
... April 4, 2011 Morphotek®, Inc., a subsidiary ... acquired certain assets relating to a proprietary tumor ... undisclosed upfront payment and future development milestones. TMI, ... PA, developed the tumor-targeting peptide (TTP) platform capable ...
... 2011 PLC Systems Inc. (OTCBB: PLCSF), a ... that final results from the REMEDIAL II investigator-sponsored ... today. The results showed that RenalGuard was much ... at preventing Contrast-Induced Nephropathy (CIN) and Dialysis in ...
Cached Medicine Technology:Morphotek®, Inc. Announces Acquisition of Tumor Targeting Assets From Transmolecular, Inc. 2Morphotek®, Inc. Announces Acquisition of Tumor Targeting Assets From Transmolecular, Inc. 3REMEDIAL II Trial of PLC's RenalGuard® Demonstrates Greater Efficacy than Current Standard of Care 2REMEDIAL II Trial of PLC's RenalGuard® Demonstrates Greater Efficacy than Current Standard of Care 3REMEDIAL II Trial of PLC's RenalGuard® Demonstrates Greater Efficacy than Current Standard of Care 4
(Date:4/17/2015)... Carolina (PRWEB) April 17, 2015 With ... Dental Care has spent the last four years ... care, performing procedures ranging from general cleanings to dental ... a grand opening at their new office in North ... same services as their Concord office, including denture fittings, ...
(Date:4/17/2015)... Nomedexamlifeinsurance.com has released a new blog post explaining ... . , Smoking is linked to numerous diseases like ... charge smokers more money for life insurance plans. Someone ... and can qualify for advantageous offers. , The ... for non-smokers. Comparing quotes is the best method of ...
(Date:4/17/2015)... April 17, 2015 Wholelifelifeinsurance.org has ... affordable whole life insurance policies . , ... provide financial security for their families at the same ... complex options which can be customized to it the ... be reduced if clients take some appropriate steps.Comparing life ...
(Date:4/17/2015)... Most people believe that starting a family ... couples, that’s not the case. Dr. Alison Zimon and Dr. ... on The Rhode Show’s program “All Things Fertility” during National ... on WPRI Channel 12. , Be sure to tune ... that can impact your chances of getting pregnant now or ...
(Date:4/17/2015)... Founder of the PACT Institute ... speaker at the Couples Conference from Friday, April 24, ... Beach, CA. Tatkin’s presentation and panel appearances at the ... become “secure-functioning” – a term he has coined after ... neurobiology, arousal regulation, and infant attachment to describe a ...
Breaking Medicine News(10 mins):Health News:Life Insurance Quotes for Smokers Available Online 2Health News:Whole Life Insurance Policies At Affordable Prices By Comparing Quotes 2Health News:Providence Fertility Center Physicians Will Be Featured on WPRI 12’s Rhode Show during National Infertility Awareness Week April 20-24 2Health News:Best-Selling Author, Therapist and Founder of the PACT Institute Will Give a Keynote Address at 2015 Couples Conference 2Health News:Best-Selling Author, Therapist and Founder of the PACT Institute Will Give a Keynote Address at 2015 Couples Conference 3
... , Jan. 15 Representatives from the ... organizations, attended the first consortium meeting aimed at developing ... lupus diagnosis, treatment, and management among minorities. The meeting, ... Atlanta, Georgia from January 12–14, 2010, was ...
... , YONKERS, N.Y. , Jan. 15 ... expressed disappointment with the U.S. Food & Drug Administration,s (FDA) ... today that there is cause for concern over its potential ... enough scientific evidence to date to warrant a ban on ...
... PHOENIX , Jan. 15 NutraCea (OTC: ... and technology, today announced a 17% reduction in its U.S. workforce ... structure. The reduction, which is anticipated to save NutraCea approximately ... NutraCea,s Brazilian subsidiary. , W. John Short , Chairman & ...
... , American Humane First to Join ... 15 The American Humane Association is part ... international group of professional animal welfare organizations committed to aiding animals ... join and commit significant resources to ARCH, which was created by ...
... NJ , Jan. 15 /PRNewswire-FirstCall/ - NUCRYST Pharmaceuticals ... be distributing to shareholders an additional supplement (the "Supplement") to ... previously delivered to shareholders in connection with the Special ... 2009 . The special meeting was originally held to consider ...
... WESTPORT, Conn. , Jan. 15 The devastating, ... a dire living situation, particularly for those Haitians living with ... to specific segments of the population, such as those victims ... dLife, which has the largest online diabetes community, aims to ...
Cached Medicine News:Health News:Lupus Foundation of America Collaborates with Federal Agencies and the U.S. Surgeon General's Office to Expand Medical Education on Lupus 2Health News:Lupus Foundation of America Collaborates with Federal Agencies and the U.S. Surgeon General's Office to Expand Medical Education on Lupus 3Health News:Consumers Union Disappointed with FDA's Action on BPA, Despite Admission of 'Some Concern' 2Health News:Consumers Union Disappointed with FDA's Action on BPA, Despite Admission of 'Some Concern' 3Health News:NutraCea Announces Reduction in Workforce in U.S. Operations 2Health News:American Humane Association Supports Animal Relief Efforts in Haiti Through International Coalition 2Health News:American Humane Association Supports Animal Relief Efforts in Haiti Through International Coalition 3Health News:NUCRYST Announces Distribution of Supplemental Information In Connection with Special Meeting of Shareholders 2Health News:NUCRYST Announces Distribution of Supplemental Information In Connection with Special Meeting of Shareholders 3Health News:NUCRYST Announces Distribution of Supplemental Information In Connection with Special Meeting of Shareholders 4Health News:dLife Connects Largest Online Diabetes Community to Facilitate Aid to Haitian Earthquake Victims Suffering From Diabetes 2
Khosla Precision and Quality in Medical and Surgical Products....
Khosla Precision and Quality in Medical and Surgical Products....
Khosla Precision and Quality in Medical and Surgical Products....
Khosla Precision and Quality in Medical and Surgical Products....
Medicine Products: